69
Participants
Start Date
June 30, 1997
Primary Completion Date
August 31, 2002
Study Completion Date
August 31, 2002
Interleukin-2
High-dose bolus interleukin-2 is a systemic therapy used to treat metastatic RCC
Our Lady of Mercy Medical Center, The Bronx
Loyola University Medical Center, Maywood
Summit Medical Center, Oakland
Cancer Center and Beckman Research Institute, City of Hope, Duarte
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
Indiana University Cancer Center, Indianapolis
Beth Israel Deaconess Medical Center, Boston
University of Michigan Comprehensive Cancer Center, Ann Arbor
Barbara Ann Karmanos Cancer Institute, Detroit
Norris Cotton Cancer Center, Lebanon
Carolinas Medical Center, Charlotte
Earle A. Chiles Research Institute at Providence Portland Medical Center, Portland
Vanderbilt-Ingram Cancer Center, Nashville
University of Texas Health Science Center at San Antonio, San Antonio
Collaborators (1)
Chiron Corporation
INDUSTRY
Loyola University
OTHER